Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jul-23 7:07 PM View:  | Adventrx Pharmaceuticals Inc. (SVRA) | 17-Jul-23 | Purchase Duplicate | 333,333 | $3.00 | $999,999.00 | 1% 24.14M to 24.47M | |
| 15-Jun-23 4:29 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Jun-23 | Acquisition (other) Duplicate | 30,000 | -- | -- | < 1% 4.19M to 4.22M | |
| 15-Jun-23 4:29 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Jun-23 | Acquisition (other) | 135 | -- | -- | < 1% 4.22M to 4.22M | |
| 15-Jun-23 4:29 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Jun-23 | Disposition (other) Duplicate | 2,030,000 | -- | -- | (48%) 4.22M to 2.19M | |
| 26-May-23 5:35 PM View: | Coursera, Inc. (COUR) | 24-May-23 | Grant | 16,186 | -- | -- | < 1% 2.24M to 2.25M | |
| 17-Mar-23 4:30 PM View: | Coursera, Inc. (COUR) | 15-Mar-23 | Sale | 1,226 | $11.82 | $14,496.60 | (< 1%) 2.24M to 2.24M | |
| 17-Feb-23 6:56 PM View: | Coursera, Inc. (COUR) | 15-Feb-23 | Acquisition (other) | 1,226 | -- | -- | < 1% 2.24M to 2.24M | |
| 02-Dec-22 5:05 PM View: | Akouos, Inc. (AKUS) | 30-Nov-22 | Disposition (change in control) Duplicate | 4,294,210 | -- | -- | (100%) 4.29M to 0 | |
| 26-May-22 6:21 PM View: | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:21 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 16-May-22 8:11 PM View: | Coursera, Inc. (COUR) | 13-May-22 | Grant | 8,655 | -- | -- | < 1% 2.23M to 2.24M | |
| 13-Apr-22 5:13 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-22 | Purchase Duplicate | 3,580,530 | $1.90 | $6,803,000.00 | 46% 7.79M to 11.37M | |
| 27-Dec-21 4:42 PM View: | Metacrine, Inc. (MTCR) | 22-Dec-21 | Market Sale Duplicate | 459,700 | $0.97 | $444,853.00 | (15%) 3.02M to 2.56M | 14% |
| 27-Dec-21 4:42 PM View: | Metacrine, Inc. (MTCR) | 10-Dec-21 | Market Sale Duplicate | 37,570 | $1.32 | $49,630.00 | (1%) 3.06M to 3.02M | 37% |
| 03-Nov-21 9:47 PM View: | Coursera, Inc. (COUR) | 01-Nov-21 | Grant | 22,985 | -- | -- | 1% 2.21M to 2.23M | |
| 19-Oct-21 9:12 PM View: | Trevi Therapeutics, Inc. (TRVI) | 18-Oct-21 | Purchase Duplicate | 1,851,850 | -- | -- | 31% 5.94M to 7.79M | |
| 30-Jun-21 6:02 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:02 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 9:29 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Conversion | 69,963,800 | -- | -- | 100% 0 to 69.96M | |
| 30-Jun-21 9:29 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Market Purchase Duplicate | 1,944,440 | $18.00 | $35,000,000.00 | 3% 69.96M to 71.91M | |
| 18-Mar-21 5:12 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 07-Dec-20 5:10 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-20 | Private Purchase Duplicate | 4,398,600 | $0.62 | $2,735,930.00 | 214% 2.05M to 6.45M | |
| 22-Sep-20 5:43 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Conversion Duplicate | 2,291,300 | -- | -- | 100% 0 to 2.29M | |
| 22-Sep-20 5:43 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Purchase Duplicate | 769,230 | $13.00 | $9,999,990.00 | 34% 2.29M to 3.06M | |
| 28-Jul-20 5:22 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jul-20 | Private Purchase Duplicate | 3,151,260 | $2.25 | $7,090,340.00 | 44% 7.23M to 10.38M | |
| 01-Jul-20 5:30 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Conversion Duplicate | 3,705,970 | -- | -- | 100% 0 to 3.71M | |
| 01-Jul-20 5:30 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Purchase Duplicate | 588,235 | $17.00 | $10,000,000.00 | 16% 3.71M to 4.29M | |
| 13-Apr-20 8:56 PM View: | Trevi Therapeutics, Inc. (TRVI) | 03-Apr-20 | Market Sale Duplicate | 564 | $2.66 | $1,500.24 | (< 1%) 5.94M to 5.94M | 54% |
| 13-Apr-20 8:56 PM View: | Trevi Therapeutics, Inc. (TRVI) | 03-Apr-20 | Exercise (in-the money or at-the-money) Duplicate | 1,500,000 | $0.00 | $1,500.00 | 34% 4.44M to 5.94M | |
| 24-Jul-19 4:53 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 22-Jul-19 | Conversion Duplicate | 3,736,240 | -- | -- | 100% 0 to 3.74M | |
| 24-Jul-19 4:53 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 22-Jul-19 | Purchase Duplicate | 450,000 | $15.00 | $6,750,000.00 | 12% 3.74M to 4.19M | |
| 25-Jun-19 4:50 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jun-19 | Market Purchase Duplicate | 2,857,140 | $3.50 | $10,000,000.00 | 65% 4.37M to 7.23M | (24%) |
| 13-May-19 5:12 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion Duplicate | 1,938,560 | -- | -- | 100% 0 to 1.94M | |
| 13-May-19 5:12 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Purchase Duplicate | 2,500,000 | $10.00 | $25,000,000.00 | 129% 1.94M to 4.44M | |
| 09-May-19 6:05 PM View: | Regulus Therapeutics Inc. (RGLS) | 07-May-19 | Private Purchase Duplicate | 1,136,700 | $1.08 | $1,227,640.00 | 124% 915.75K to 2.05M | |
| 19-Feb-19 5:02 PM View: | Genocea Biosciences, Inc. (GNCA) | 14-Feb-19 | Private Purchase Duplicate | 9,948,270 | $0.47 | $4,688,620.00 | 40% 25.0M to 34.95M |